Knopp Biosciences Overview
- Year Founded
-
2004
- Status
-
Acquired/Merged
- Employees
-
6
- Latest Deal Type
-
M&A
Knopp Biosciences General Information
Description
Developer of immunological and neurological drugs designed to change the course of human health. The company's drugs are dexpramipexole, which are small molecules of immunological therapeutics based on its pre-clinical and clinical activity in modulating white blood cells, enabling medical professionals to address unmet needs and thereby improve their patients' lives.
Contact Information
Website
www.knoppbio.comCorporate Office
- 2403 Sidney Street
- Suite 206
- Pittsburgh, PA 15203
- United States
Corporate Office
- 2403 Sidney Street
- Suite 206
- Pittsburgh, PA 15203
- United States
Knopp Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. Merger/Acquisition | 01-Apr-2022 | Completed | Clinical Trials - Phase 2 | |||
| 13. Later Stage VC | Completed | Clinical Trials - Phase 2 | ||||
| 12. Later Stage VC (Series C) | 11-Nov-2020 | Completed | Clinical Trials - Phase 2 | |||
| 11. Grant | 22-Jul-2020 | Completed | Clinical Trials - General | |||
| 10. Debt - PPP | 14-Apr-2020 | Completed | Clinical Trials - General | |||
| 9. Grant | 01-Jan-2019 | Completed | Clinical Trials - General | |||
| 8. Secondary Transaction - Private | Completed | Clinical Trials - General | ||||
| 7. Later Stage VC | 01-Jan-2014 | Completed | Clinical Trials - General | |||
| 6. Later Stage VC | 01-Nov-2012 | $30M | $119M | Completed | Clinical Trials - General | |
| 5. Later Stage VC | 18-Aug-2010 | $60M | $88.6M | Completed | Clinical Trials - General |
Knopp Biosciences Comparisons
Industry
Financing
Details
Knopp Biosciences Competitors (23)
One of Knopp Biosciences’s 23 competitors is Herophilus, a Formerly VC-backed company based in San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Herophilus | Formerly VC-backed | San Francisco, CA | ||||
| Cerecin | Venture Capital-Backed | Broomfield, CO | ||||
| CervoMed | Formerly VC-backed | Boston, MA | ||||
| Neurona Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| T3D Therapeutics | Venture Capital-Backed | Durham, NC |
Knopp Biosciences Patents
Knopp Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250171429-A1 | Pyrazolyl compounds as kv7 channel activators | Pending | 23-Feb-2022 | ||
| US-20250230152-A1 | Pyrazolyl compounds as kv7 channel activators | Active | 23-Feb-2022 | ||
| US-20260200908-A1 | Pyrazolyl compounds as kv7 channel activators | Pending | 23-Feb-2022 | ||
| WO-2022031956-A1 | Use of dexpramipexole for the treatment of moderate to severe asthma | Inactive | 05-Aug-2020 | ||
| EP-4031548-A1 | Methods of use for kv7 channel activators | Inactive | 17-Sep-2019 | A61K31/4184 |
Knopp Biosciences Signals
Knopp Biosciences Former Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Biogen | Corporation | Minority | ||
| Innovation Works | Venture Capital | Minority | ||
| Kramer Capital Partners | Investment Bank | Minority | ||
| LaunchCyte | Venture Capital | Minority | ||
| Angel (individual) | Minority |
Knopp Biosciences FAQs
-
When was Knopp Biosciences founded?
Knopp Biosciences was founded in 2004.
-
Where is Knopp Biosciences headquartered?
Knopp Biosciences is headquartered in Pittsburgh, PA.
-
What is the size of Knopp Biosciences?
Knopp Biosciences has 6 total employees.
-
What industry is Knopp Biosciences in?
Knopp Biosciences’s primary industry is Drug Discovery.
-
Is Knopp Biosciences a private or public company?
Knopp Biosciences is a Private company.
-
What is Knopp Biosciences’s current revenue?
The current revenue for Knopp Biosciences is .
-
How much funding has Knopp Biosciences raised over time?
Knopp Biosciences has raised $202M.
-
Who are Knopp Biosciences’s investors?
Biogen, Innovation Works, Kramer Capital Partners, LaunchCyte, and are 5 of 12 investors who have invested in Knopp Biosciences.
-
Who are Knopp Biosciences’s competitors?
Herophilus, Cerecin, CervoMed, Neurona Therapeutics, and T3D Therapeutics are some of the 23 competitors of Knopp Biosciences.
-
When was Knopp Biosciences acquired?
Knopp Biosciences was acquired on 01-Apr-2022.
-
Who acquired Knopp Biosciences?
Knopp Biosciences was acquired by Biohaven.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process